Of note, GM-CSF production is not restricted to Th1 cells; in fact, Th17 cells from patients with inflammatory conditions including inflammatory bowel disease (IBD) and multiple sclerosis (MS) have been shown to produce GM-CSF ex vivo [34]. Here, CSF2 is linked to inflammatory bowel disease.